Ayten Kayı Cangır, MD, Professor, FEBTS, works at the Ankara University Faculty of Medicine in the Department of Thoracic Surgery, and the Ankara University Medical Design Application and Research Center (MEDITAM), 06100, Sıhhiye, Ankara, Turkey.
Dr. Kayı Cangır is a Professor in the Department of Thoracic Surgery at Ankara University, Turkey. Her areas of expertise include lung cancer, malignant mesothelioma, thymic tumors, esophageal cancer and the surgical treatment of thoracic outlet syndrome. Dr. Kayı Cangır is a member of the IASLC Lung Staging and Prognostic Factors Committee, the IASLC Mesothelioma Committee and the IASLC Thymic Malignancy Staging and Prognostic Factors Committee.
Dr.Kayı Cangır was honored by the IASLC Board of Directors Executive Committee with the 2021 Clifton F. Mountain Lectureship Award for Staging in recognition of her longstanding work in the field of thoracic surgery.
Dr. Kayı Cangır focuses her research on thymic epithelial tumors, PM and lung tumors. In 2015, she joined the International Thymic Malignancy Interest Group. She has multiple publications on prognostic factors, staging, radiomics–histologic correlation and the surgical treatment of thymic epithelial tumors and lung cancer.
Ayten Kayı Cangır, MD, Professor, FEBTS, works at the Ankara University Faculty of Medicine in the Department of Thoracic Surgery, and the Ankara University Medical Design Application and Research Center (MEDITAM), 06100, Sıhhiye, Ankara, Turkey.
Dr. Kayı Cangır is a Professor in the Department of Thoracic Surgery at Ankara University, Turkey. Her areas of expertise include lung cancer, malignant mesothelioma, thymic tumors, esophageal cancer and the surgical treatment of thoracic outlet syndrome. Dr. Kayı Cangır is a member of the IASLC Lung Staging and Prognostic Factors Committee, the IASLC Mesothelioma Committee and the IASLC Thymic Malignancy Staging and Prognostic Factors Committee.
Dr.Kayı Cangır was honored by the IASLC Board of Directors Executive Committee with the 2021 Clifton F. Mountain Lectureship Award for Staging in recognition of her longstanding work in the field of thoracic surgery.
Dr. Kayı Cangır focuses her research on thymic epithelial tumors, PM and lung tumors. In 2015, she joined the International Thymic Malignancy Interest Group. She has multiple publications on prognostic factors, staging, radiomics–histologic correlation and the surgical treatment of thymic epithelial tumors and lung cancer.